Composition for preventing or treating dry eye syndrome containing α-humulene as active ingredient
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 26, 2023
Grant Date -
Feb 11, 2021
app pub date -
Dec 28, 2018
filing date -
Jan 31, 2018
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating dry eye syndrome and a health functional food composition for preventing or improving dry eye syndrome including α-humulene as an active ingredient, wherein the α-humulene improves the expression level of mucin and recovers the reduced amount of tears in the dry eye-induced eye and thus can effectively prevent, improve or treat dry eye syndrome.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully